| |
|
|
|
Harvard Bioscience  
|
|
3.58 -0.04 (-0.01%) |
08-14 13:53 |
|
Open: |
3.59 |
Pre close: |
3.62 |
Target:
|
4.49
|
|
High: |
3.7346 |
Low: |
3.48 |
Resistance:
|
3.84
4.40
|
|
Volume: |
46,640 |
Market Cap: |
139M |
Support:
|
2.94
2.45
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
3.77
 |
MACD |
MACD(12,26):
|
0.14 |
|
MA(20): |
3.46  |
Signal(12,26,9): |
0.14 |
|
MA(100): |
2.92 |
Stochastic Oscillator |
%K(14,3):
|
46.63 |
|
MA(250): |
2.86 |
%D(3): |
55.88 |
|
Average Volume(K) |
3-Month: |
29003
|
52-Week |
High:
|
4.40 |
|
10-Days: |
18883 |
Low: |
1.39 |
|
RSI |
RSI(14):
|
50.43 |
Change(%): |
39.7 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.181 |
Return on Equity (ttm) |
-8.7 |
Shares Out. (M) |
38.38 |
|
EPS Est. Current Year |
0.130 |
Return on Assets (ttm) |
-0.4 |
Shares Float (M) |
34.05 |
|
EPS Est. Next Year |
0.170 |
PEG Ratio |
0.00 |
% Held by Insiders |
14.80 |
|
EPS Est. Next Quarter |
0.040 |
Qtrly Rev. Growth |
-15.7 |
% Held by Institutions |
67.77 |
|
Forward EPS |
-0.080 |
Gross Profit (p.s.) |
1.682 |
Shares Short (K) |
2450 |
|
Book Value (p.s.) |
1.980 |
EBITDA (p.s.) |
0.172 |
P/E |
-19.29 |
|
Sales Per Share |
2.912 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.76 |
|
Profit Margin |
-6.11 |
Operating Cash Flow
(M) |
8.91 |
P/S |
1.20 |
|
Operating Margin |
-0.97 |
Levered Free Cash Flow
(M) |
11.02 |
P/CF |
15.04 |
|
|
|
|
|
|
